AD-MCI

Clinical trials for AD-MCI explained in plain language.

Never miss a new study

Get alerted when new AD-MCI trials appear

Sign up with your email to follow new studies for AD-MCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could one stem cell infusion slow Alzheimer's decline?

Disease control Recruiting now

This study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…

Matched conditions: AD-MCI

Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control

Last updated Jun 10, 2026 13:27 UTC

AD-MCI

Get alerted when new AD-MCI trials appear

Could one stem cell infusion slow Alzheimer's decline?